Sr Product Manager, Pulse Ox
Danaher Corporation
Summary
The Sr Product Manager, Pulse Ox is responsible for driving the development and execution of the commercial marketing strategy for the Masimo Pulse Ox portfolio. You will collaborate with cross-functional teams, field sales/clinical teams and other relevant stakeholders in the development and execution of the strategic marketing plan.
Job description
In this role, you will have the opportunity to:
- Manage overall global marketing strategy and plan for the Pulse Ox portfolio, including product objectives, competitive analysis, positioning strategies and revenue projections.
- Direct marketing initiatives/campaigns to support overall advancement, adoption, and acceleration of the product portfolio.
- Develop commercial tools and sales collateral that powerfully communicate the portfolio’s value proposition.
Requirements
- 7+ years of experience in product management, project management, commercial strategy, or technical role.
- Bachelor’s degree in marketing, business, engineering and/or Lifesciences.
- Prior experience working within a medical devices or life sciences company.
- Prior experience with sales, marketing, and engineering teams.
- FDA and international medical device regulatory processes (preferred).
- Proficient in CRM software such as Salesforce.com (preferred).
Benefits
- Paid time off
- Medical, Dental & Vision
- 401(k)
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.